The level of DNA modification by (+)-syn-(11S,12R,13S,14R)- and (-)-anti-(11R,12S,13S,14R)- dihydrodiol epoxides of dibenzo[a,l]pyrene determined the effect on the proteins p53 and p21(WAF1) in the human mammary carcinoma cell line MCF-7

Carcinogenesis

Volumn 20, Issue 5, 1999, Pages 859-865

  Luch, Andreas ^a,b   Kudla, Kim ^c   Seidel, Albrecht ^d   Doehmer, Johannes ^b   Greim, Helmut ^b,e   Baird, William M ^a  

^a OREGON STATE UNIVERSITY   (United States)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c PURDUE UNIVERSITY   (United States)

^d JOHANNES GUTENBERG UNIVERSITY   (Germany)

^e INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BENZO[A]PYRENE DERIVATIVE; CYCLIN DEPENDENT KINASE INHIBITOR; DNA; EPOXIDE; POLYCYCLIC AROMATIC HYDROCARBON; PROTEIN P21; PROTEIN P53;

ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CELL STRAIN MCF 7; CONTROLLED STUDY; DNA ADDUCT; DNA DAMAGE; DNA MODIFICATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0032961705     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/20.5.859     Document Type: Article

References (45)

1. Cavalieri,E.L., Higginbotham,S., RamaKrishna,N.V.S., Devanesan,P.D., Todorovic,R., Rogan,E.G. and Salmasi,S. (1991) Comparative dose-response tumorigenicity studies of dibenzo[a,l]pyrene versus 7,12-dimethylbenz[a]anthracene, benzo[a]pyrene and two dibenzo[a,l]pyrene dihydrodiols in mouse skin and rat mammary gland. Carcinogenesis, 12, 1939-1944.
2. Higginbotham,S., RamaKrishna,N.V.S., Johansson,S.L., Rogan,E.G. and Cavalieri,E.L. (1993) Tumor-initiating activity and carcinogenicity of dibenzo[a,l]pyrene versus 7,12-dimethylbenz[a]anthracene and benzo[a]pyrene at low doses in mouse skin. Carcinogenesis, 14, 875-878.
3. LaVoie,E.J., He,Z.-M., Meegalla,R.L. and Weyand,E.H. (1993) Exceptional tumor-initiating activity of 4-fluorobenzo[j]fluoranthene on mouse skin: comparison with benzo[j]fluoranthene, 10-fluoro-benzo[j]fluoranthene, benzo[a]pyrene, dibenzo[a,l]pyrene and 7,12-dimethylbenz[a]anthracene. Cancer Lett., 70, 7-14.
4. DeRatt,W.K., Kooijman,S.A.L.M. and Gielen,J.W.J. (1987) Concentrations of polycyclic hydrocarbons in airborne particles in the Netherlands and their correlation with mutagenicity. Sci. Total. Environ., 66, 95-114.
5. Kozin,I.S., Gooijer,C. and Velthorst,N.H. (1995) Direct determination of dibenzo[a,l]pyrene in crude extracts of environmental samples by laser excited Shpol'skii spectroscopy. Anal. Chem., 67, 1623-1626.
6. Mumford,J.L., Harris,D.B., Williams,K., Chuang,J.C. and Cooke,M. (1987) Indoor air sampling and mutagenicity studies of emissions from unvented coal combustion. Environ. Sci. Technol., 21, 308-311.
7. Mumford,J.L., Xueming,L., Fuding,H., Xu,B.L. and Chuang,J.C. (1995) Human exposure and dosimetry of polycyclic aromatic hydrocarbons in urine from Xuan Wei, China with high lung cancer mortality associated with exposure to unvented coal smoke. Carcinogenesis, 16, 3031-3036.
8. Snook,M.E., Severson,R.F., Arrendale,R.F., Higman,H.C. and Chortyk,O.T. (1977) The identification of high molecular weight polynuclear aromatic hydrocarbons in a biologically active fraction of cigarette smoke condensate. Beitr. Tabakforsch., 9, 79-101.
9. Ralston,S.L., Lau,H.H.S., Seidel,A., Luch,A., Platt,K.L. and Baird,W.M. (1994) Identification of dibenzo[a,l]pyrene-DNA adducts formed in cells in culture and in mouse skin. Polycyclic Aromat. Comp., 6, 199-206.
10. Ralston,S.L., Seidel,A., Luch,A., Platt,K.L. and Baird,W.M. (1995) Stereoselective activation of dibenzo[a,l]pyrene to (-)-anti(11R, 12S,13S,14R)- and (+)-syn(11S,12R,13S,14R)-11,12-diol-13,14-epoxides which bind extensively to deoxyadenosine residues of DNA in the human mammary carcinoma cell line MCF-7. Carcinogenesis, 16, 2899-2907.
11. Li,K.-M., Todorovic,R., Rogan,E.G., Cavalieri,E.L., Ariese,F., Suh,M., Jankowiak,R. and Small,G.J. (1995) Identification and quantitation of dibenzo[a,l]pyrene-DNA adducts formed by rat liver microsomes in vitro: preponderance of depurination adducts. Biochemistry, 34, 8043-8049.
12. Luch,A., Glatt,H.-R., Platt,K.L., Oesch,F. and Seidel,A. (1994) Synthesis and mutagenicity of the diastereomeric fjord-region 11,12-dihydrodiol 13,14-epoxides of dibenzo[a,l]pyrene. Carcinogenesis, 15, 2507-2516.
13. Gill,H.S., Kole,P.L., Wiley,J.C., Li,K.M., Higginbotham,S., Rogan,E.G. and Cavalieri,E.L. (1994) Synthesis and tumor-initiating activity in mouse skin of dibenzo[a,l]pyrene syn- and anti-fjord-region diolepoxides. Carcinogenesis, 15, 2455-2460.
14. Amin,S., Krzeminski,J., Rivenson,A., Kurtzke,C., Hecht,S.S. and El-Bayoumy,K. (1995) Mammary carcinogenicity in female CD rats of fjord region diol epoxides of benzo[c]phenanthrene, benzo[g]chrysene and dibenzo[a,l]pyrene. Carcinogenesis, 16, 1971-1974.
15. Amin,S., Desai,D., Dai,W., Harvey,R.G. and Hecht,S.S. (1995) Tumorigenicity in newborn mice of fjord region and other sterically hindered diol epoxides of benzo[g]chrysene, dibenzo[a,l]pyrene (dibenzo[def,p]chrysene), 4H-cyclopenta[def]chrysene and fluoranthene. Carcinogenesis, 16, 2813-2817.
16. Melendez-Colon,V.J., Smith,C.A., Seidel,A., Luch,A., Platt,K.-L. and Baird,W.M. (1997) Formation of stable adducts and absence of depurination DNA adducts in cells and DNA treated with the potent carcinogen dibenzo[a,l]pyrene or its diol epoxides. Proc. Natl Acad. Sci. USA, 94, 13542-13547.
17. Luch,A., Seidel,A., Glatt,H.-R. and Platt,K.L. (1997) Metabolic activation of the (+)-S,S- and (-)-R,R-enantiomers of trans-11,12-dihydroxy-11,12-dihydrodibenzo[a,l]pyrene: stereoselectivity, DNA adduct formation, and mutagenicity in Chinese hamster V79 cells. Chem. Res. Toxicol., 10, 1161-1170.
18. Ralston,S.L., Coffing,S.L., Seidel,A., Luch,A., Platt,K.L. and Baird,W.M. (1997) Stereoselective activation of dibenzo[a,l]pyrene and its trans-11,12-dihydrodiol to fjord region 11,12-diol 13,14-epoxides in a human mammary carcinoma MCF-7 cell-mediated V79 cell mutation assay. Chem. Res. Toxicol., 10, 687-693.
19. WAF1 in the human mammary carcinoma cell line MCF-7. Polycyclic Aromat. Comp., 10, 299-306.
20. Bjelogrlic,N., Mäkinen,M., Stenbäck,F. and Vähäkangas,K. (1994) Benzo[a]pyrene-7,8-diol-9,10-epoxide-DNA adducts and increased p53 protein in mouse skin. Carcinogenesis, 15, 771-774.
21. Rämet,M., Castrén,K., Järvinen,K., Pekkala,K., Turpeenniemi-Hujanen,T., Soini,Y., Pääkkö,P. and Vähäkangas,K. (1995) p53 protein expression is correlated with benzo[a]pyrene-DNA adducts in carcinoma cell lines. Carcinogenesis, 16, 2117-2124.
22. waf1/cip1. Carcinogenesis, 18, 2313-2318.
23. Yuan,J., Yeasky,T.M., Havre,P.A. and Glazer,P.M. (1995) Induction of p53 in mouse cells decreases mutagenesis by UV radiation. Carcinogenesis, 16, 2295-2300.
24. Kastan,M.B., Onyekwere,O., Sidransky,D., Vogelstein,B. and Craig,R.W. (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Res., 51, 6304-6311.
25. Fritsche,M., Haessler,C. and Brandner,G. (1993) Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. Oncogene, 8, 307-318.
26. 1 arrest and apoptosis. Cancer Res., 54, 1169-1174.
27. 1 cyclin-dependent kinases. Cell, 75, 805-816.
28. Marx,J. (1994) New link found between p53 and DNA repair. Science, 266, 1321-1322.
29. Ford,J.M. and Hanawalt,P.C. (1995) Li-Fraumeni syndrome fibroblasts homozygous for p53 mutations are deficient in global DNA repair but exhibit normal transcription-coupled repair and enhanced UV resistance. Proc. Natl Acad. Sci. USA, 92, 8876-8880.
30. Shaw,P., Bovey,R., Tardy,S., Sahli,R., Sordat,B. and Costa,J. (1992) Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc. Natl Acad. Sci. USA, 89, 4495-4499.
31. Hartwell,L.H. and Kastan,M.B. (1995) Cell cycle control and cancer. Science, 266, 1821-1828.
32. Harris,C.C. and Hollstein,M. (1993) Clinical implications of the p53 tumor-suppressor gene. N. Engl. J. Med., 329, 1318-1327.
33. Runnebaum,I.B., Nagarajan,M., Bowman,M., Soto,D. and Sukumar,S. (1991) Mutations in p53 as potential molecular markers for human breast cancer. Proc. Natl Acad. Sci. USA, 88, 10657-10661.
34. 35S]phosphorothioate labeling and HPLC. Carcinogenesis, 12, 885-893.
35. Harlow,E. and Lane,D. (1988) Antibodies - A Laboratory Manual. Sigma, Cold Spring Harbor Laboratory, NY.
36. Barnes,D.W. (1984) Growth characteristics of A431 human epidermoid carcinoma cells in serum-free medium: inhibition by epidermal growth factor. Adv. Exp. Med. Biol., 172, 49-66.
37. Reiss,M., Brash,D.E., Munoz-Antonia,T., Simon,J.A., Ziegler,A., Vellucci,V.F. and Zhou,Z.-L. (1992) Status of the p53 tumor suppressor gene in human squamous carcinoma cell lines. Oncology Res., 4, 349-357.
38. Sayer,J.M., Yagi,H., Silverton,J.V., Friedman,S.L., Whalen,D.L. and Jerina,D.M. (1982) Conformational effects in the hydrolyses of rigid benzylic epoxides: implications for diol epoxides of polycyclic hydrocarbons. J. Am. Chem. Soc., 104, 1972-1978.
39. WAF1 and cell-cycle arrest in human cells in culture. Polycyclic Aromat. Comp., in press.
40. El-Deiry,W.S., Tokino,T., Velculescu,V.E., Levy,D.B., Parsons,R., Trent,J., Lin,D., Mercer,W.E., Kinzler,K.W. and Vogelstein,B. (1993) WAF1, a potential mediator of p53 tumor suppression. Cell, 75, 817-825.
41. Sheikh,M.S., Li,X.-S., Chen,J.-C., Shao,Z.-M., Ordonez,J.V. and Fontana,J.A. (1994) Mechanisms of regulation of WAF1/Cip1 gene expression in human breast carcinoma: role of p53-dependent and independent signal transduction pathways. Oncogene, 9, 3407-3415.
42. Nurse,P. (1990) Universal control mechanism regulating onset of M-phase. Nature, 344, 503-508.
43. Xiong,Y., Hannon,G.J., Zhang,H., Casso,D., Kobayashi,R. and Beach,D. (1993) p21 is a universal inhibitor of cyclin kinases. Nature, 366, 701-704.
44. 1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev., 8, 2540-2551.
45. 1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc. Natl Acad. Sci. USA, 92, 8493-8497.